Sign in to fuzzto save your conversations, follow your research and come back anytime.

In the news

Medi Assist Healthcare Gets Buy Rating with ₹477 Target

Medi Assist Q1 profit jumps 23.57% to ₹27.68 cr, revenue up 24%

Medi Assist integrates UIDAI's Aadhaar verification, stock up 0.79%

Medi Assist Attracts Wall Street Giants Despite Stock Decline

Medi Assist shares surge 4.61% on strong Q3 results, turns debt-free
The Quarter story
The two most recent quarterly results, compared side-by-side.
Medi Assist delivers steady revenue growth and strong market share gains, though seasonal profit dips and retention slips require monitoring.
EBITDA grows from ₹42.0 in Q1 FY26 to ₹48.0 in Q1 FY27, confirming sustained profitability.
Adjusted PAT falls from ₹46.3 in Q3 FY26 to ₹24.5 in Q1 FY27, signaling seasonal compression.
Group and Retail market share rises from 23.1% in Q1 FY26 to 24.3% in Q1 FY27, reflecting successful repositioning.
Claims processed drops from 22 in Q1 FY26 to 2.69 in Q1 FY27, indicating severe volume contraction.
Total Income expands from ₹198.0 in Q1 FY26 to ₹247.0 in Q1 FY27, confirming consistent revenue growth.
PUM retention slips from 93.4% in Q1 FY26 to 90.2% in Q1 FY27, warning of emerging churn risks.
Technology revenue contribution increases from 2.5% in Q1 FY26 to 3.3% in Q1 FY27, confirming digital growth.
Group and Retail premiums administered decline from ₹25,923.2 in Q4 FY26 to ₹8,975 in Q1 FY27, indicating seasonal booking patterns.
Group market share climbs from 33.2% in Q1 FY26 to 37.6% in Q1 FY27, showing strong portfolio gains.
International revenue contribution shrinks from 5.6% in Q1 FY26 to 4.5% in Q4 FY26, indicating shrinking segment impact.